Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

Reichard, 1991, Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years, J Intern Med, 230, 101, 10.1111/j.1365-2796.1991.tb00415.x

1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401

Ohkubo, 1995, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study, Diabetes Res Clin Pract, 28, 103, 10.1016/0168-8227(95)01064-K

1996, UK Prospective Diabetes Study 17: A nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus, Ann Intern Med, 124, 136, 10.7326/0003-4819-124-1_Part_2-199601011-00011

Fuller, 1979, Hyperglycaemia and coronary heart disease: the Whitehall Study, J Chronic Dis, 32, 721, 10.1016/0021-9681(79)90051-1

Balkau, 1998, High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men, Diabetes Care, 21, 360, 10.2337/diacare.21.3.360

1978, Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes VII: mortality and selected nonfatal events with insulin treatment, JAMA, 240, 37, 10.1001/jama.1978.03290010041020

1976, A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes, Diabetes, 25, 1129, 10.2337/diab.25.12.1129

Smits, 1995, Cardiovascular effects of sulphonylurea derivatives, Diabetologia, 38, 116, 10.1007/BF02369361

Pogatsa, 1995, Potassium channels in the cardiovascular system, Diabetes Res Clin Pract, 28, S91, 10.1016/0168-8227(95)01103-K

Stout, 1992, Insulin and atherosclerosis, 165

Genuth, 1996, Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus, Ann Intern Med, 124, 104, 10.7326/0003-4819-124-1_Part_2-199601011-00005

1991, UK Prospective Diabetes Study VIII: study design, progress and performance, Diabetologia, 34, 877, 10.1007/BF00400195

1959, Net weight standard for men and women, Stat Bull Metrop Insur Co, 40, 1

1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8

Hypertension in Diabetes Study, 1996, Therapeutic requirements to maintain tight blood pressure control, Diabetologia, 39, 1554, 10.1007/s001250050614

Holman, 1996, Glycaemic improvement over one year in a double-blind trial of acarbose in 1,946 NIDDM patients, Diabetologia, 39, A44

1994, UK Prospective Diabetes Study XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects, Diabet Med, 11, 534, 10.1111/j.1464-5491.1994.tb02032.x

Manley, 1992, Decreases in albumin/creatinine and N-acetylglucosaminidase/creatinine ratios in urine samples stored at −20°C, Clin Chem, 38, 2294, 10.1093/clinchem/38.11.2294

1978

1992, UK Prospective Diabetes Study IX: relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months diet therapy, Diabetologia, 36, 835

1998, Report of the expert committee on the diagnosis and classification of diabetes mellitus, Diabetes Care, 21, 55

1985

Stout, 1990, Insulin and atheroma: 20-yr perspective, Diabetes Care, 13, 631, 10.2337/diacare.13.6.631

Pyörälä, 1979, Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland, Diabetes Care, 2, 131, 10.2337/diacare.2.2.131

Desprès, 1996, Hyperinsulinemia as an independent risk factor for ischemic heart disease, N Engl J Med, 334, 952, 10.1056/NEJM199604113341504

Davies, 1989, Long term effectiveness of photocoagulation for diabetic maculopathy, Eye, 3, 764, 10.1038/eye.1989.119

1984, Photocoagulation for proliferative diabetic retinopathy: a randomised controlled clinical trial using the xenon-arc, Diabetologia, 26, 109

Schmitt, 1993, Hypertension secondary to chlorpropamide with amelioration by changing to insulin, Am J Hypertens, 6, 317

Melander, 1988, Sulphonylureas in the treatment of non-insulin-dependent diabetes, Baillieres Clin Endocrinol Metab, 2, 443, 10.1016/S0950-351X(88)80042-9

1995, Adverse events and their association with treatment regimens in the Diabetes Control and Complications Trial, Diabetes Care, 18, 1415, 10.2337/diacare.18.11.1415

1995, UK Prospective Diabetes Study 16: overview of six years' therapy of type 2 diabetes - a progressive disease, Diabetes, 44, 1249, 10.2337/diab.44.11.1249

1998, UK Prospective Diabetes Study 26: sulphonylurea failure in non-insulin dependent diabetic patients over 6 years, Diabet Med, 15, 297, 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W

1998, UK Prospective Diabetes Study 28: a randomised trial of efficacy of early addition of metformin in sulphonylurea treated non-insulin dependent diabetes, Diabetes Care, 21, 87, 10.2337/diacare.21.1.87

Kumar, 1996, Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients, Diabetologia, 39, 701, 10.1007/BF00418542

Chiasson, 1996, The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial, Ann Intern Med, 121, 928, 10.7326/0003-4819-121-12-199412150-00004

Birkeland, 1996, NIDDM: a rapid progressive disease, Diabetologia, 39, 1629, 10.1007/s001250050626

Yki-Järvinen, 1992, Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus, N Engl J Med, 327, 1426, 10.1056/NEJM199211123272005

Chow, 1995, Comparison of insulin with or without continuation of oral hypoglycaemic agents in the treatment of secondary failure in NIDDM patients, Diabetes Care, 18, 307, 10.2337/diacare.18.3.307

1998, Standards of medical care for patients with diabetes mellitus, Diabetes Care, 21, S23

Abraira, 1995, Veterans Affairs Cooperative Study on glycemic control and complications in Type II diabetes (VACSDM), Diabetes Care, 18, 1113, 10.2337/diacare.18.8.1113

Henry, 1993, Intensive conventional insulin therapy for type II diabetes: metabolic effects during a 6 month outpatient trial, Diabetes Care, 16, 21, 10.2337/diacare.16.1.21

Hayward, 1997, Starting insulin therapy in patients with Type 2 diabetes, JAMA, 278, 1663, 10.1001/jama.1997.03550200039029

Dunn, 1996, Standards of care of diabetic patients in a typical English community, Br J Gen Pract, 46, 401

1998, Clinical practice recommendations 1998, Diabetes Care, 21, S20

de Courten, 1997, Screening for non-insulin-dependent diabetes mellitus: where to draw the line?, Diabet Med, 14, 5, 10.1002/(SICI)1096-9136(199702)14:2<95::AID-DIA333>3.0.CO;2-K

UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ (in press).